“Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010” presented by Prof. Jürgen Gschwend at EAU22.
Also watch the interview with Prof. Gschwend on this presentation.